4,714 Shares in Inogen, Inc. (NASDAQ:INGN) Bought by AlphaQuest LLC

AlphaQuest LLC purchased a new position in shares of Inogen, Inc. (NASDAQ:INGN) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 4,714 shares of the medical technology company’s stock, valued at approximately $43,000.

Several other institutional investors have also bought and sold shares of INGN. Connor Clark & Lunn Investment Management Ltd. grew its holdings in Inogen by 312.5% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 174,625 shares of the medical technology company’s stock worth $1,694,000 after buying an additional 132,287 shares in the last quarter. Royce & Associates LP grew its holdings in Inogen by 167.4% during the third quarter. Royce & Associates LP now owns 51,891 shares of the medical technology company’s stock worth $503,000 after buying an additional 32,482 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in Inogen by 23.5% during the fourth quarter. Bank of New York Mellon Corp now owns 126,461 shares of the medical technology company’s stock worth $1,160,000 after buying an additional 24,082 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in Inogen by 2.7% during the third quarter. JPMorgan Chase & Co. now owns 896,106 shares of the medical technology company’s stock worth $8,692,000 after buying an additional 23,891 shares in the last quarter. Finally, Barclays PLC grew its holdings in Inogen by 72.9% during the third quarter. Barclays PLC now owns 55,508 shares of the medical technology company’s stock worth $539,000 after buying an additional 23,398 shares in the last quarter. Institutional investors own 89.94% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on INGN. StockNews.com downgraded Inogen from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Needham & Company LLC restated a “hold” rating on shares of Inogen in a research note on Wednesday, February 26th.

Inogen Price Performance

Shares of NASDAQ:INGN opened at $7.45 on Friday. The company has a market capitalization of $197.65 million, a PE ratio of -3.31 and a beta of 1.15. The business has a fifty day moving average price of $9.79 and a two-hundred day moving average price of $9.73. Inogen, Inc. has a 1 year low of $6.14 and a 1 year high of $13.33.

Inogen Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.